PEAK6’s Insmed INSM Stock Holding History

PEAK6’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,300	Closed	-$3.01M	–	2994
2025 Q4	$3.01M	Sell	17,300 -149,200	-90%	-$27.2M	0.01%	1213
2025 Q3	$24M	Buy	+166,500	New	+$20.4M	0.04%	365

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PEAK6's INSM Position: Q1 2026 in Review

PEAK6 reduced its Insmed (INSM) stake by 64% in Q1 2026, selling an estimated $2.19M and leaving 7,926 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

PEAK6 first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.86M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

PEAK6 held 7,926 shares of Insmed worth $1.3M as of Q1 2026.
PEAK6 sold 14,264 Insmed shares in Q1 2026, an estimated $2.19M.
Insmed made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #1584 holding.
PEAK6 first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
PEAK6's Insmed position peaked at $3.86M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.